Bruker Corporation (BRKR)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 204,500 | 544,900 | 413,000 | 390,100 | 222,200 |
| Revenue | US$ in thousands | 3,366,400 | 2,964,500 | 2,530,700 | 2,417,900 | 1,987,500 |
| Pretax margin | 6.07% | 18.38% | 16.32% | 16.13% | 11.18% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $204,500K ÷ $3,366,400K
= 6.07%
Bruker Corporation's pretax margin has shown fluctuations over the past five years. The trend indicates a gradual increase from 11.18% in December 2020 to 18.38% in December 2023, reflecting improving profitability levels. However, there was a significant decline to 6.07% by December 2024. It is essential for the company to investigate the reasons behind this decrease to address any underlying issues affecting profitability and ensure sustained financial performance in the future.
Peer comparison
Dec 31, 2024
Company name
Symbol
Pretax margin
Bruker Corporation
BRKR
6.07%
Avantor Inc
AVTR
12.59%
Bio-Rad Laboratories Inc
BIO
-16.04%
Cytek Biosciences Inc
CTKB
-8.14%
Illumina Inc
ILMN
-26.97%
Mettler-Toledo International Inc
MTD
26.79%
Revvity Inc.
RVTY
11.01%
Waters Corporation
WAT
25.83%